River Vision Development Corp.'s Series D Round

River Vision Development Corp. raised a round of funding on January 21, 2016.

River Vision Development Corp. specializes in the development of teprotumumab, a therapy for an eye condition called Graves' ophthalmopathy.…

Articles about River Vision Development Corp.'s Series D Round: